Collegium Pharmaceutical Inc Revenue per Employee (COLL), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Collegium Pharmaceutical Inc   (NASDAQ: COLL)
 

Collegium Pharmaceutical Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 6.67% in the second quarter 2026, year on year to cumulative value of $752 million, Collegium Pharmaceutical Inc 's revenue per employee grew on a trailing twelve months basis to $ 1,777,173, this is below the company average.
Within the Healthcare sector Employees of 41 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 495, from total ranking in previous quarter at 566. Collegium Pharmaceutical Inc has 423 employees.


What is Sales per Employee Ratio?







COLL Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 6.67 % -22.6 % 12.92 % 31.72 % 29.4 %
Sales per Employee (TTM) $ 1,777,173 1,747,636 1,842,383 1,786,827 1,667,733
COLL's Total Ranking # 495 # 566 # 483 # 513 # 546
Seq. Revenue Change 45.63 % -33.2 % -1.78 % 11.63 % 5.67 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 29
Healthcare Sector # 42
Overall Market # 495

Revenue per Employee Statistics
High Average Low
$ 1,842,383 $ 999,281 $ 17,596
(Dec 31 2025)   (Jun 30 2017)



Financial Statements
Collegium Pharmaceutical Inc 's Revenue MRQ $ 200 Millions Visit COLL's Income Statement
Collegium Pharmaceutical Inc 's Revenues TTM $ 752 Millions Visit COLL's aggregate revenue growth
What are COLL's Sales? Visit COLL's Sales by Segment




Other Ratios
Collegium Pharmaceutical Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
COLL's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for COLL's Competitors
Revenue per Employee for COLL's Suppliers
Revenue per Employee for COLL's Customers

You may also want to know
COLL's Sales Growth Rates COLL's Pe Price to earnings ratio COLL's Receivables Turnover Ratio COLL's Stock Quote
COLL's Net Income Growth Rates COLL's Ps Price to Sales ratio COLL's Sales per Employee COLL's Asset Turnover Ratio
COLL's Net Margin COLL's Pb Price to Book ratio COLL's Financial Strength Ratios COLL's Dividend Payout Ratio
Date modified: 2026-09-06T17:15:04+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Eton Pharmaceuticals Inc   2,392,704.55 $ 105.279  Million 44 
Cormedix Inc   2,366,196.28 $ 451.943  Million 191 
Elite Pharmaceuticals Inc   2,155,839.86 $ 140.130  Million 65 
Liquidia Corporation  2,087,532.41 $ 450.907  Million 216 
Privia Health Group Inc   1,923,384.18 $ 2,358.069  Million 1,226 
Fennec Pharmaceuticals Inc   1,692,028.57 $ 59.221  Million 35 
Neurocrine Biosciences Inc   1,686,950.00 $ 3,373.900  Million 2,000 
Tarsus Pharmaceuticals Inc   1,638,732.43 $ 606.331  Million 370 
Agenus Inc  1,638,185.19 $ 132.693  Million 81 
Xenetic Biosciences Inc   1,630,388.50 $ 3.261  Million
Ideaya Biosciences Inc   1,614,668.97 $ 234.127  Million 145 
Rigel Pharmaceuticals Inc  1,590,718.39 $ 276.785  Million 174 
Progyny Inc   1,531,890.19 $ 1,311.298  Million 856 
Cue Biopharma Inc   1,298,413.79 $ 37.654  Million 29 
Arvinas Inc   1,287,398.37 $ 316.700  Million 246 
Travere Therapeutics Inc   1,189,798.79 $ 591.330  Million 497 
Heron Therapeutics Inc   1,183,648.44 $ 151.507  Million 128 
Journey Medical Corp  1,175,534.48 $ 68.181  Million 58 
Theravance Biopharma inc   1,159,011.11 $ 104.311  Million 90 
Corcept Therapeutics Inc  1,138,100.00 $ 830.813  Million 730 
Biomarin Pharmaceutical Inc  1,057,626.20 $ 3,406.614  Million 3,221 
Hims and Hers Health Inc   1,055,894.35 $ 2,578.494  Million 2,442 
Assembly Biosciences Inc   1,025,273.97 $ 74.845  Million 73 
Sanara Medtech Inc   1,019,592.91 $ 110.116  Million 108 
Ani Pharmaceuticals Inc  1,008,638.14 $ 978.379  Million 970 
Coya Therapeutics Inc   1,002,393.13 $ 8.019  Million
Meiragtx Holdings Plc  986,354.84 $ 397.501  Million 403 
Arrowhead Pharmaceuticals Inc   941,624.47 $ 669.495  Million 711 
Scilex Holding Company  929,647.06 $ 31.608  Million 34 
The Oncology Institute Inc   916,137.29 $ 587.244  Million 641 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.